Allworth Financial’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.5K | Buy |
541
+4
| +0.7% | +$455 | ﹤0.01% | 1823 |
|
|
2025
Q1 | $58.3K | Buy |
537
+21
| +4% | +$2.28K | ﹤0.01% | 1475 |
|
|
2024
Q4 | $59.8K | Buy |
516
+1
| +0.2% | +$116 | ﹤0.01% | 1489 |
|
|
2024
Q3 | $51.5K | Hold |
515
| – | – | ﹤0.01% | 1395 |
|
|
2024
Q2 | $51.4K | Buy |
515
+360
| +232% | +$35.9K | ﹤0.01% | 1376 |
|
|
2024
Q1 | $11.3K | Hold |
155
| – | – | ﹤0.01% | 2051 |
|
|
2023
Q4 | $11.1K | Sell |
155
-25
| -14% | -$1.79K | ﹤0.01% | 1944 |
|
|
2023
Q3 | $10.8K | Buy |
180
+31
| +21% | +$1.86K | ﹤0.01% | 1813 |
|
|
2023
Q2 | $10.7K | Hold |
149
| – | – | ﹤0.01% | 1838 |
|
|
2023
Q1 | $11K | Hold |
149
| – | – | ﹤0.01% | 1760 |
|
|
2022
Q4 | $9.95K | Sell |
149
-98
| -40% | -$6.55K | ﹤0.01% | 1688 |
|
|
2022
Q3 | $13K | Buy |
+247
| New | +$13K | ﹤0.01% | 1491 |
|